Naxim (Ambroxol Hydrochloride)

Ambroxol Hydrochloride acts as a mucolytic agent that reduces mucus viscosity in various respiratory disorders.

• Acute respiratory tract infections: improves mucus clearance and eases cough symptoms.
• Chronic bronchitis: helps reduce sputum production and facilitates expectoration.
• Chronic obstructive pulmonary disease (COPD): supports airway patency by thinning secretions and improving breathing comfort.

• Ambroxol stimulates the production of pulmonary surfactant and enhances the activity of serine proteases, which break down mucopolysaccharide fibers. This reduces the viscosity of bronchial secretions, making them less sticky and easier to transport by ciliary action and cough, thereby promoting effective clearance of mucus from the airways.

Adverse reactions may occur with Ambroxol use, ranging from mild to serious.

Common Side Effects

• Taste disturbance: altered or unpleasant taste in the mouth.
• Nausea: feeling of queasiness often without vomiting.
• Vomiting: expulsion of stomach contents.
• Diarrhea: loose, frequent stools.
• Abdominal pain: discomfort or cramps in the stomach area.
• Headache: mild to moderate pain in the head.

Serious or Rare Side Effects

• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Eosinophilia: elevated eosinophil count in blood.
• Liver enzyme elevation: increased ALT/AST indicating hepatic stress.
• Neutropenia: reduced neutrophil count, increasing infection risk.
• Acute bronchospasm: sudden narrowing of airways causing breathing difficulty.

When using Ambroxol, certain precautions should be observed to ensure safe therapy.

• Assess renal function: adjust use in patients with impaired kidney function.
• Use with caution in asthma: monitor for bronchospasm.
• Avoid in known hypersensitivity: discontinue if allergic signs appear.
• Do not exceed recommended duration: prolonged use may increase risk of side effects.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ambroxol may interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Concurrent use with codeine‑containing antitussives: may increase risk of respiratory depression.
• Combination with other mucolytics: can cause excessive thinning of secretions.
• Co‑administration with drugs known for severe allergic potential: may amplify hypersensitivity reactions.

Moderate Interactions (Monitor Closely)

• Warfarin: monitor INR as Ambroxol may affect anticoagulation.
• NSAIDs: possible increase in gastric irritation.
• Oral contraceptives: may reduce hormonal efficacy; consider alternative contraception.